Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
暂无分享,去创建一个
J. Krischer | M. Redondo | G. Eisenbarth | Liping Yu | D. Schatz | S. Babu | C. Greenbaum | J. Palmer | T. Orbán | D. Cuthbertson | A. Zeidler
[1] Heather J Cordell,et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. , 2004, The Journal of clinical endocrinology and metabolism.
[2] J. Krischer,et al. High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial—Type 1 Diabetes , 2004, Diabetologia.
[3] J. Ilonen,et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. , 2003, Tissue antigens.
[4] J. Ilonen,et al. Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children. , 2003, The Journal of clinical endocrinology and metabolism.
[5] J. Krischer,et al. Diabetes Prevention Trial 1 , 2002, Annals of the New York Academy of Sciences.
[6] C. Greenbaum,et al. ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types. , 2002, Journal of autoimmunity.
[7] J. Todd,et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. , 2001, Human molecular genetics.
[8] J. Krischer,et al. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. , 2001, Diabetes.
[9] E. Thorsby,et al. DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. , 2000, The Journal of clinical endocrinology and metabolism.
[10] G. Eisenbarth,et al. Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1. , 2000, The Journal of clinical endocrinology and metabolism.
[11] M. Rewers,et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Erlich,et al. Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[13] M. Rewers,et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. , 1996, The Journal of clinical endocrinology and metabolism.
[14] G. Eisenbarth,et al. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele. , 1996, Journal of autoimmunity.
[15] H. Erlich,et al. HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM , 1995, Diabetes.
[16] J. Todd,et al. A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.
[17] J. Krischer,et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. , 1994, The Journal of clinical investigation.
[18] J. Todd,et al. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Todd,et al. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.